Aspirin and breast cancer prevention - A link to ER status

Breast Cancer Research

Volumn 6, Issue 5, 2004, Pages 211-212

  Tait, Catherine R ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; ESTROGEN RECEPTOR; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTAGLANDIN;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; BREAST CANCER; BREAST CARCINOGENESIS; BREAST FEEDING; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; FAMILY HISTORY; GENE EXPRESSION; HUMAN; MITOGENESIS; MORBIDITY; MUTAGENESIS; PARITY; POSTMENOPAUSE; PROSTAGLANDIN SYNTHESIS INHIBITION; REVIEW; RISK REDUCTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; ASPIRIN; BREAST NEOPLASMS; CYCLOOXYGENASE INHIBITORS; HUMANS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 4544380911     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr923     Document Type: Review

References (8)

1. Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenso JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A: Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the womn's health initiative. Cancer Res 2003, 63:6096-6101.
2. Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI: Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 2004, 291: 2433-2440.
3. Gupta RA, Dubois RN: Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001, 1:111-121.
4. Zhao Y, Agarwal VR, MendelsonCR, Simpson ER: Estrogen biosynthesis proximal to a breast tumour is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase gene). Endocrinology 1996, 137:5739-5742.
5. Khuder SA, Mutgi AB. Breast cancer and NSAID use: a meta-analysis. Br J Cancer 2001, 84:1188-1192.
6. Yoshimura N, Sano H, Okamoto M, Akioks K, Ushigome H, Kadotani Y, Yoahimura R, Nobori S, Higuchi A, Ohmori Y, Nakamura K: Expression of cyclooxygenase-1 and -2 in human breast cancer. Surg Today 2003, 33:805-811.
7. Kundu N, Fulton AM: Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer. Cancer Res 2002, 62:2343-2346.
8. Davies GLS: Cyclooxygenase-2 and chemoprevention of breast cancer. J Steroid Biochem 2003, 86:495-499.